Corbus Pharmaceuticals Holdings (CRBP) Change in Accured Expenses (2013 - 2025)

Corbus Pharmaceuticals Holdings' Change in Accured Expenses history runs 13 years deep, the most recent figure standing at $4.9 million for Q3 2025.

• In Q3 2025, Change in Accured Expenses rose 248.02% year-over-year to $4.9 million; the TTM figure through Sep 2025 stood at $5.4 million (up 1507.29% YoY), while the FY2024 annual figure was -$5.6 million, down 211.53% from the prior year.
• Change in Accured Expenses was $4.9 million for Q3 2025 at Corbus Pharmaceuticals Holdings, up from $1.7 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $4.9 million in Q3 2025 to a low of -$4.6 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged -$496804.2 across 5 years, with a median of -$49050.0 in 2023.
• The sharpest annual moves came in 2021 and 2024: Change in Accured Expenses slumped 484.0% in 2021, then surged 2322.22% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at -$3.5 million in 2021, then jumped by 133.06% to $1.2 million in 2022, then soared by 198.98% to $3.5 million in 2023, then slumped by 150.03% to -$1.7 million in 2024, then soared by 382.44% to $4.9 million in 2025.
• The last three Change in Accured Expenses figures came in at $4.9 million (Q3 2025), $1.7 million (Q2 2025), and $476000.0 (Q1 2025), per Business Quant data.